Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2015-08-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that three-dimensional measurements of diabetic foot ulcers are feasible in the assessment of wound healing. A prospective cohort study is conducted in which newly admitted patients with a diabetic foot ulcer are included at the first visit at the multidisciplinary clinic. The patients are followed for one year or until complete wound healing, amputation or death. The four wound measurements: 2D area, 3D area, perimeter and volume are measured using the 3D-WAM camera with frequent intervals. Patient anthropometrics and wound data are collected during the study and correlated to the wound healing.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of 3D Imaging Ulcer Camera
NCT03063138
3D Camera - Telemedical Foot Ulcer Treatment
NCT01870934
Shockwave Therapy of Chronic Diabetic Foot Ulcers
NCT02251418
Online Wound Electronic Medical Record (OWEMR) to Decrease Amputations in Diabetics
NCT01371318
Non-Invasive Testing to Evaluate Wound Healing in Diabetes
NCT04232631
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Newly admitted patients with a diabetic foot ulcer are included at the first visit in the multidisciplinary clinic. The data mentioned below are collected at the first visit and the following examinations are performed including 3D photos. The wound size (2D area, 3D area, perimeter and volume) are estimated from the photos using the 3D-WAM camera. The wound examination is repeated after 2, 4, 8, 12, 24, 36 and 52 weeks or until healing of the wound. The wound healing is estimated using changes in wound size per time unit. Patients are treated by standard ulcer treatment methods and are unaffected by the project per se. During the trial the different methods of treatment are noted including changes from initial treatment. The variables will be quantified after one year depending on time to heal, establishment of a chronic ulcer (non-healing after one year) or an amputation has been performed.
At baseline the following patient data will be collected:
* Demographic data: gender, age
* Smoking habits
* Time period between onset of wound to first visit in the multidisciplinary clinic
* Body Mass Index
* Comorbidity using Charlson Comorbidity Index score
* Type of diabetes, duration of diabetes
* Diabetic complications including retinopathy, albuminuria, coronary heart diseases and neuropathy
The following examinations will be performed at baseline:
* Blood pressure measurement
* Peripheral blood pressure
* Examination for neuropathy using monofilament
* Blood samples from patients with a diabetic foot ulcer
The clinical examination of the ulcer are performed at baseline and after 2, 4, 8, 12, 24, 36 and 52 weeks or until wound healing:
* Size of wound (2D area, 3D area, perimeter, volume) measured using the 3D-WAM camera
* Size of wound in 2D area using the digital imaging method with the software ImageJ
* Location of the ulcer
* Classification of ulcer: granulation, necrosis, epithelialisation
* Secretory potential
* Foot deformity
* Bone affection - if osteitis is suspected an x-ray is taken
* Signs of infection
The different types of ulcer treatment is registered for every ulcer:
* Type of bandage
* Antibiotics (local, systemic)
* Revision (method, frequency),
* Surgery
Effect variables
* Wound 2D area, 3D area, perimeter and volume
* Variation in 2D and 3D area measurements during the study period
* Percentage change in wound size after 2, 4, 8, 12, 24, 36 and 52 weeks
Endpoints
* Wound healing
* Amputations
* Chronic wound (non-healing after 1 year)
* Death
Significance
This project seeks to clarify whether 3D photos of wounds will provide accurate structural measures to illuminate the background for delayed ulcer healing, and thereby to create platform for a more evidence based treatment algorithm.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diabetic foot ulcers
Newly referred patients with diabetic foot ulcers from the multidisciplinary clinic: University Centre for Wound healing, Odense University Hospital, Denmark.
3D Wound Assessment Monitor (WAM) camera
Three-dimensional wound measurement (2D area, 3D area, perimeter, volume) using 3D-WAM camera
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3D Wound Assessment Monitor (WAM) camera
Three-dimensional wound measurement (2D area, 3D area, perimeter, volume) using 3D-WAM camera
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years or older
Exclusion Criteria
* Non-compliance (dementia, mental disorders)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Southern Denmark
OTHER
Odense University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Line Bisgaard Jørgensen
MD, PhD student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Knud Yderstræde, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Endocrinology, Odense University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Centre of Wound Healing, Odense University Hospital (OUH)
Odense, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OUH3D02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.